Memphasys Secures TGA Approval for Felix System
Filed with ASX · · 3 pages · English
• Following CE Mark approval in Europe and existing compliance in selected international markets, TGA approval establishes Australia as a major high-regulatory commercial market for Felix™ • Early approval accelerates activation of advanced commercial discussions and revenue generation Importantly, TGA approval has been granted approximately two months ahead of the Company’s previously guided time
Story so far
Earlier from Memphasys
- Memphasys announces successful $800,000 Capital Raising
- Trading Halt
- Regulatory Submissions Lodged for Felix
- Qatar's largest IVF Institution Places MENA Orders for Felix
- Memphasys Extends Convertible Note Repayment Terms
Later from Memphasys
- Appendix 4D - Half-year Financial Report - 31 December 2025
- MENA Orders Secured, Expanded & Operations Unaffected
- Investor Presentation - April 2026
- Quarterly Activities/Appendix 4C Cash Flow Report
- ITL Orders 1000 Felix Cartridges Across MENA Markets
Follow Memphasys into a list and get an email when it puts out news.
Follow Memphasys